Conflicting roles of <i>EGFR</i> expression by subtypes in breast cancer.
Masanori Oshi, Shipra Gandhi, Yoshihisa Tokumaru, Li Yan, Akimitsu Yamada, Ryusei Matsuyama, Takashi Ishikawa, Itaru Endo, Kazuaki Takabe
Abstract
expression in ER-positive/HER2-negative breast cancer is associated with improved outcomes and an anti-cancer immune microenvironment.
Topics & Concepts
Breast cancerImmune systemCancer researchEpidermal growth factor receptorMedicineCancerBiologyInternal medicineOncologyImmunologyHER2/EGFR in Cancer ResearchCancer Immunotherapy and BiomarkersCancer Cells and Metastasis